ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Rigshospitalet (Copenhagen University Hospital) at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Rigshospitalet (Copenhagen University Hospital) takes part in 8 sessions at ESMO 2026 in Madrid. Its program covers precision treatment and outcomes across gastrointestinal, gynaecological and other cancers. It reports a trial of olaparib, durvalumab and a vaccine as maintenance treatment for recurrent ovarian cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
National university hospital of Denmark in Copenhagen, affiliated with the University of Copenhagen.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Poster
Sun Oct 25
12:00–12:45
Talk
Mon Oct 26
08:30–08:50
Clonal haematopoiesis and cancer risk: Precursor, biomarker, or prevention target?
ESMO-ESC: Joining forces - Shared mechanisms and opportunities for cardiovascular and cancer prevention
Poster
Mon Oct 26
12:00–12:45

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Rigshospitalet (Copenhagen University Hospital)

Tell us what you sell and we’ll find the people at Rigshospitalet (Copenhagen University Hospital) most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction